ArticleJournal of bioenergetics and biomembranes2026
Effects of 3',4'-dihydroxyflavonol treatment on Neu N and BDNF and ICAM levels in the striatum of rats subjected to transient bilateral carotid occlusion-induced ischemia-reperfusion.
Article in Journal of bioenergetics and biomembranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral infarction is a leading cause of severe long-term disability and functional and cognitive impairment. With the advancement of acute stroke treatment, more patients are now experiencing stroke with varying degrees of impairment. The present study was conducted to determine the effects of 1-week 3,4-dihydroxyflavonol (DiOHF) administration during transient experimental cerebral ischemia-reperfusion (I/R) in rats on NeuN, Tuba1a, Tubb3, and calbindin were evaluated as markers of neuronal phenotype and cytoskeletal organization, while ICAM and BDNF were assessed in relation to inflammatory and neurotrophic processes. Changes in these markers indicate alterations in neuronal marker expression, cytoskeletal integrity, and neurotrophic and inflammatory status. In this study, a total of 28 male Wistar albino rats, aged 10-12 weeks and weighing 300-400 g, were used. 1-Control Group (n = 6): The animals in this group received no anaesthesia or surgical procedures. 2-Sham Group (n = 6): After general anaesthesia was induced in the animals in this group, the carotid artery regions were opened and closed. 3- Ischemia-Reperfusion Group (n = 8): Under general anaesthesia, the carotid arteries of the rats were isolated and ligated for 30 min, followed by ischemia. 4- Ischemia-Reperfusion + DiOHF Group (n = 8): Under general anaesthesia, the carotid arteries of the rats were ligated for 30 min, followed by ischemia. Reperfusion was then allowed. Tuba1A, Tubb3, ICAM and Calbindin were analyzed by real-time PCR, BDNF by a commercial ELISA kit, and NeuN by immunohistochemistry. I/R decreased the levels of Neu N, Tuba1a, Tubb3, calbindin and BDNF in the striatum tissues and increased ICAM levels. DiOHF supplementation halted the decrease in expression level in Tuba1a, Tubb3, Calbindin, BDNF; the Increase in Icam level.Also DiOHF supplementation prevented the decrease in the level of anti-NeuN antibody and led to an increase. The study results revealed that one week of transient I/R in rats suppressed NeuN, TUBA1A, TUBB3, calbindin and BDNF levels, which are important in neuronal phenotype and cytoskeletal organization inflammatory and neurotrophic processes. However, a week DiOHF treatment significantly corrected the distortions caused by I/R.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.